Novel Skin Care Product for the Management of Acute Radiodermatitis

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

June 13, 2023

Study Completion Date

June 13, 2023

Conditions
Radiodermatitis; AcuteRadiation Dermatitis
Interventions
OTHER

Hydrating emollient for acute radiodermatitis

"The emollient has a calming effect, and hydrating and anti-oxidative properties.~An absorbable wound dressing will be applied on painful and moist wounds. In case of severe itch, a systemic antihistaminic agent can be prescribed by the radiotherapist."

OTHER

Standard institutional skin care

The control patients will receive the institutional standard skin care, which includes the application of Flamigel® (Flen Pharma, Kontich, BELGIUM). In addition, Mepilex® (Mölnlycke Health Care, Berchem, Belgium), an absorbable wound dressing will be applied on painful and moist wounds. In case of severe itch, a systemic antihistaminic agent can be prescribed by the radiotherapist.

Trial Locations (1)

3500

Jessa Ziekenhuis VZW, Hasselt

All Listed Sponsors
collaborator

Hasselt University

OTHER

lead

Jessa Hospital

OTHER